drugset
drugset / Trial / NCT00000240

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

NCT00000240 ↗

Phase 2 Completed University of Vermont National Institute on Drug Abuse (NIDA) · collab
Open-labelTreatment

Summary

The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.

Timeline

Start
1999-04
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — —

Indications

substance-related disorder